P62 knockdown HCC cells had similar expression of Keap1, Nrf2 and HO-1 and similar reaction to combination treatment compared with Nrf2 knockdown HCC cells, which indicated p62-Keap1-Nrf2 was the main signaling pathway in the combination treatment. This evidence concerns the gene KEAP1 and hepatocellular carcinoma.